These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2032659)

  • 1. Use of pig hepatocytes to study the inhibition of monoamine oxidase by furazolidone.
    Hoogenboom LA; Tomassini O; Oorsprong MB; Kuiper HA
    Food Chem Toxicol; 1991 Mar; 29(3):185-91. PubMed ID: 2032659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a furazolidone metabolite responsible for the inhibition of amino oxidases.
    Timperio AM; Kuiper HA; Zolla L
    Xenobiotica; 2003 Feb; 33(2):153-67. PubMed ID: 12623758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of furaltadone by pig hepatocytes and Salmonella typhimurium TA 100 bacteria, and the formation of protein-bound metabolites.
    Hoogenboom LA; Polman TH; Lommen A; Huveneers MB; van Rhijn J
    Xenobiotica; 1994 Aug; 24(8):713-27. PubMed ID: 7839695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors and histamine metabolism.
    Benedetti MS; Ancher JF; Sontag N
    Experientia; 1980 Jul; 36(7):818-10. PubMed ID: 6772465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone: a new analytical method for their detection.
    Hoogenboom LA; van Kammen M; Berghmans MC; Koeman JH; Kuiper HA
    Food Chem Toxicol; 1991 May; 29(5):321-8. PubMed ID: 2060890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.
    Benedetti MS; Boucher T; Carlsson A; Fowler CJ
    Biochem Pharmacol; 1983 Jan; 32(1):47-52. PubMed ID: 6830619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
    Ask AL
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):56-63. PubMed ID: 6493351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranbezolid, a novel oxazolidinone antibacterial: in vivo characterisation of monoamine oxidase inhibitory potential in conscious rats.
    Naruganahalli KS; Shirumalla RK; Bansal V; Gupta JB; Das B; Ray A
    Eur J Pharmacol; 2006 Sep; 545(2-3):167-72. PubMed ID: 16899241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoamine oxidase-B inhibitor, MD 780236, metabolized essentially by the A form of the enzyme in the rat.
    Strolin Benedetti M; Dow J
    J Pharm Pharmacol; 1983 Apr; 35(4):238-45. PubMed ID: 6133934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of type A monoamine oxidase by coptisine in mouse brain.
    Ro JS; Lee SS; Lee KS; Lee MK
    Life Sci; 2001 Dec; 70(6):639-45. PubMed ID: 11833714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.
    Flanagan S; Bartizal K; Minassian SL; Fang E; Prokocimer P
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3060-6. PubMed ID: 23612197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of p-chloramphetamine on the inactivation of monoamine oxidase in rat brain by 3-amino-2-oxazolidinone, 2-hydroxyethylhydrazine and pheylisopropylhydrazine.
    Fuller RW; Roush BW
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):134-40. PubMed ID: 666453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. I. Inhibition by a selective monoamine oxidase-B inhibitor, MD 780236.
    Kinemuchi H; Morikawa F; Ueda T; Arai Y
    Jpn J Pharmacol; 1986 Jun; 41(2):183-9. PubMed ID: 3747265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ; Benedetti MS
    J Neurochem; 1983 Jun; 40(6):1534-41. PubMed ID: 6406646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the present state of MAO inhibitors.
    Strolin Benedetti M; Dostert P
    J Neural Transm Suppl; 1987; 23():103-19. PubMed ID: 3108452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of heterocyclic reversible monoamine oxidase-B inactivators into irreversible inactivators by N-methylation.
    Ding CZ; Silverman RB
    J Med Chem; 1993 Nov; 36(23):3606-10. PubMed ID: 8246228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.